At Generic Oncology, we understand that the information we provide is as critical as the medications we supply. Our mission is to empower patients, caregivers, and healthcare providers with accurate, science-backed, and up-to-date information about oncology treatments and generic medicine accessibility.
This Editorial Policy outlines the rigorous standards we follow to ensure our content is trustworthy, objective, and medically sound.

Our Mission: Integrity in Oncology Information

We are dedicated to bridging the gap between high costs and essential care. Our content focuses on:

Explaining complex oncology treatments in clear, accessible language.
Providing transparent information about generic equivalents and bio-similarity.
Guiding international patients through the legal and logistical aspects of medicine importation.

Content Creation & Medical Accuracy

We do not rely on automated generation for our medical advice. Every article, guide, and product description undergoes a strict creation process:

Research: Our writers utilize only high-authority medical sources, including peer-reviewed journals (e.g., The Lancet, NEJM), regulatory databases (FDA, EMA), and manufacturer prescribing information (Beacon, Incepta, Renata, Everest Pharmaceuticals, and more on).
Medical Review: All clinical content is reviewed by our Medical Review Board, led by licensed pharmacists and oncology specialists, including Dr. Salma Elreedy. This ensures that dosage, side effects, and indication data are clinically accurate.
Human Oversight: While we leverage technology for formatting, all medical claims are verified by human experts to prevent hallucinations or inaccuracies common in AI-generated text.

Sourcing & Citations

We believe in radical transparency. You will see direct citations in our articles linking to:

Clinical Trials: Data from ClinicalTrials.gov or PubMed.
Regulatory Approvals: Official approval notices from the US FDA or Bangladesh Directorate General of Drug Administration (DGDA).
Manufacturer Data: Official Leaflets and Prescribing Information.
We strictly avoid using non-medical blogs, forums, or unverified Wikipedia entries as primary sources.

Independence & Objectivity

Generic Oncology is a pharmaceutical distributor. However, our educational content is strictly separated from our sales goals.

Unbiased Reporting: We provide objective information about all available generic options for a specific molecule, not just the ones we have in stock.
No Pay-for-Play: We do not accept payments from pharmaceutical manufacturers to favor their specific brand in our medical guides. Our recommendations are based on quality certifications (WHO-GMP, US-FDA) and clinical equivalence.

Corrections & Updates

Oncology is a rapidly evolving field. If new clinical data emerges or a regulatory status changes, we update our content immediately.

Corrections: Significant errors are corrected transparently, with a note at the top of the article explaining the change.
Timestamps: We display the “Last Updated” date on all medical articles so you know the information is current.

Feedback

If you believe any information on our site is inaccurate or outdated, please contact our Editorial Team immediately at info@genericoncology.com. We review all medical feedback within 48 hours.